Depression Following Traumatic Brain Injury: Epidemiology, Risk Factors and Management

Author： Rapoport Mark J.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.26, Iss.2, 2012-02, pp. : 111-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroprotective agents in traumatic brain injury

By Maas A.I.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. : 753-767

Informa Healthcare

Access to resources Recommend Favorite

Adenosine Neuromodulation and Traumatic Brain Injury

By  

Current Neuropharmacology, Vol. 7, Iss. 3, 2009-09 ,pp. : 228-237

Bentham Science Publishers

Access to resources Recommend Favorite

Biomarkers in Silent Traumatic Brain Injury

By  

Current Pharmaceutical Design, Vol. 22, Iss. 6, 2016-02 ,pp. : 680-687

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative Stress in Traumatic Brain Injury

By  

Current Medicinal Chemistry, Vol. 21, Iss. 10, 2014-04 ,pp. : 1201-1211

Bentham Science Publishers

Access to resources Recommend Favorite

Influence of Glutamine on Intestinal Inflammatory Response, Mucosa Structure Alterations and Apoptosis Following Traumatic Brain Injury in Rats

By Feng D   Xu W   Chen G   Hang C   Gao H   Yin H  

The Journal of International Medical Research, Vol. 35, Iss. 5, 2007-09 ,pp. : 644-656

Field House Publishing

Access to resources Recommend Favorite